Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2026-01-05 @ 7:14 PM
Study NCT ID:
NCT03119467
Status:
TERMINATED
Last Update Posted:
2019-12-27
First Post:
2017-04-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas
Sponsor:
Rhizen Pharmaceuticals SA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-11
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-19
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-10
First Submit QC Date:
None
Study First Post Date:
2017-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-26
Last Update Post Date:
2019-12-27
Last Update Post Date Type:
ACTUAL